AstraZeneca Aktie
155,00
EUR
+0,55
EUR
+0,36
%
144,58
CHF
-0,75
CHF
-0,51
%
Werbung
AstraZeneca Aktie Analyse
| 05.04.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 22.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 18.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 08.03.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 07.03.22 | AstraZeneca Buy | UBS AG | |
| 07.03.22 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
|
Werbung
|
|||
| 23.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.02.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 18.02.22 | AstraZeneca Buy | UBS AG | |
| 16.02.22 | AstraZeneca Buy | UBS AG | |
| 16.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.02.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.02.22 | AstraZeneca Overweight | Barclays Capital | |
| 14.02.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 10.02.22 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.02.22 | AstraZeneca Buy | UBS AG | |
| 10.02.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 31.01.22 | AstraZeneca Overweight | Barclays Capital | |
| 20.01.22 | AstraZeneca Buy | Deutsche Bank AG | |
| 19.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 07.12.21 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 22.11.21 | AstraZeneca Buy | Kepler Cheuvreux | |
| 17.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 17.11.21 | AstraZeneca Buy | UBS AG | |
| 15.11.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 15.11.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 12.11.21 | AstraZeneca Buy | UBS AG | |
| 12.11.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 12.11.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.21 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.11.21 | AstraZeneca Overweight | Barclays Capital | |
| 02.11.21 | AstraZeneca Buy | UBS AG | |
| 26.10.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 25.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 20.10.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 19.10.21 | AstraZeneca Buy | UBS AG | |
| 18.10.21 | AstraZeneca Buy | Kepler Cheuvreux | |
| 15.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.10.21 | AstraZeneca Buy | UBS AG | |
| 13.10.21 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 11.10.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 11.10.21 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.09.21 | AstraZeneca Buy | Deutsche Bank AG | |
| 28.09.21 | AstraZeneca Outperform | Credit Suisse Group | |
| 28.09.21 | AstraZeneca Buy | Jefferies & Company Inc. | |
Werbung
Werbung